Penumbra, Inc. PEN NYSE

Penumbra, Inc. (PEN) reported total assets of $1.83B and total liabilities of $398.92M for fiscal year 2025, resulting in total equity of $1.43B.

The company held $186.9M in cash and short-term investments. Total debt stood at $219.7M, with net debt of $32.8M. The Debt-to-Equity (D/E) ratio was 0.15 (conservative).

Current ratio is 6.64, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.15, current ratio of 6.64 — balance sheet is strong
• MOAT (80/100) — Total assets $1.83B and equity $1.43B support the company's competitive scale
• VALUE (32/100) — Debt-to-Equity 0.15 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 67/100 with 3/7 criteria passed.

DXCM

DexCom, Inc.

$62.95

-0.27%

PODD

Insulet Corporation

$201.49

+1.86%

ALGN

Align Technology, Inc.

$184.69

+2.23%

GMED

Globus Medical, Inc.

$94.94

+2.11%

SWAV

ShockWave Medical, Inc.

$334.75

-0.02%

DVA

DaVita Inc.

$149.45

-1.39%

MASI

Masimo Corporation

$178.39

-0.04%

BAX

Baxter International Inc.

$17.59

-0.23%